Executive Board

Executive Board

STADA's Executive Board manages the Company with the goal of sustainable added value in its own responsibility in consideration of the concerns of the shareholders, its employees and other groups connected to the Company. The members of the Executive Board are jointly responsible for corporate governance. The Executive Board runs the businesses in accordance with the legal requirements, the Articles of Incorporation, the rules of procedure and the schedule of responsibilities.


Peter Goldschmidt, Chairman of the Executive Board/CEO

(under contract until 08/31/2021)

Curriculum Vitae Peter Goldschmidt

born October 19,1964

Peter Goldschmidt has 28 years’ experience and success in the pharmaceutical industry with Novartis Pharma. He worked in OTC, Generics and the innovative Pharma Business in Asia, Europe and the US in several different leadership functions. From 2013 through 2018, Peter Goldschmidt was President of Sandoz US and Head of North America. He served on the Board of Directors as Vice Chair of Association for Accessible Medicines (AAM), the generics and biosimilar industry association in the U.S. Prior to this, Head of Sandoz Central and Eastern Europe and member of the Global Sandoz Executive Committee.

While at Sandoz North America he led the organization through several years of growth in the US through its generic and biosimilar portfolio expansion. By building a strong diverse leadership team he creates and a culture where associates are purpose-driven, resilient, engaged and thrive in the face of challenges. Peter Goldschmidt’s focus is on driving growth by expanding the portfolio and having strong partnerships in production and commercial activities while ensuring superior customer relations, strong supply chain reliability, ultimately leading to increased market share.

A German national, he is a graduate in politics and economic geography – and hold a master’s degree in sociology – from the University of Muenster in Germany. He has completed post-graduate studies at the London Business School, UK, and at the Harvard Business School and Stanford Business School in the US.

Mark Keatley, Chief Financial Officer/CFO

(under contract until 09/26/2020)
Curriculum Vitae Mark Keatley
born November 3, 1957

Professional Experience:

Since September 27, 2017                                     

Chief Financial Officer at STADA Arzneimittel AG
(under contract until 09/26/2020)

2013 - 2017

Partner at Albrecht, Prock & Partners AG, Switzerland

2005 - 2012            

Chief Financial Officer of Actavis Group, Iceland

2002 - 2005
Chief Financial Officer at Famar S.A., Greece

2001 - 2002

Chief Financial Officer at Ardana Biosciences Ltd., United Kingdom
1994 - 2000

Chief Financial Officer at Ashanti Goldfields Corporation, Ghana

1986 - 1994

Division Manager und Investment Officer at International Finance Corporation, USA

1984 - 1986
Master of Business Administration, Stanford Business School, USA

1980 - 1984
Financial Analyst, Ford Motor Company, United Kingdom

1976 - 1980
Master’s degrees in History and International Relations, Cambridge University, United Kingdom


Miguel Pagan Fernandez, Chief Technical Officer/CTO

(under contract until 06/30/2021)

Curriculum Vitae Miguel Pagan Fernandez
born on April 2,1965

Professional Experience:

Since July 1, 2018                                              

Chief Technical Officer (CTO) at STADA Arzneimittel AG
(under contract until 06/30/2021)

2015 - June 30, 2018

Head of Global Technical Operations (Solids and Special Technologies), Novartis & Member of the Sandoz Executive Committee acting as Global Head of Technical Operations

2014 - 2015

Head of Technical Operations Europa & India, Sandoz-Novartis
2012 - 2014Vice President of Americas and Consumer Care Operations, Merck & Co (MSD)
2011 - 2012

Associate Vice President Pharmaceutical Operations-Puerto Rico,  
Merck & Co (MSD)
2007 - 2011
General Manager of Las Piedras, Puerto Rico
2003 - 2006 Plant Manager, Schering-Plough, Madrid, Spain
2001 - 2003Quality Head & Technical Director, Schering-Plough, Madrid, Spain
1995 - 2001

Pharmaceutical & Analytical Development Manager & Technical Director, CEPA Schwarz Pharma
1990 - 1995

Production Manager, Institute Berna Biotech (Crucell Biotechnology)

EducationDoctorate program in Pharmacy, Complutense University of Madrid, Spain
MBA/ Project Management, Commerce Association and Education
Master in Industrial Pharmacy, Complutense University of Madrid, Spain
Executive Program, Harvard Business School and Wharton. University of Pennsylvania
Bachelors of Pharmacy at Complutense University of Madrid, Spain

Details on the remuneration of the members of the Executive Board can be found in the Remuneration Report in the Corporate Governance section under “Executive Board remuneration”.

Career at STADA

Career at STADA

STADA's employees, with their extensive expertise, their experience and their strong commitment, play an important part in the longstanding success of the Group.

Learn more

Investor Relations

Investor Relations

Here you can find all the facts and background information about the STADA securities.

Learn more



For STADA "All the best" means taking responsibility.

Learn more